The largest medtech companies have differing business development strategies, but tend to be on the same page on R&D spending.
Suddenly 2020’s medtech M&A landscape looks very different.
As Smiths Group delays its split partly so it can focus on ventilator production, the US FDA grants emergency authorisation to other breathing devices to treat Covid-19.
Digital health is a core focus for Philips. Might more acquisitions be on the way?
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
Vascular robotics is growing fast and Corindus is the leader here, but Healthineers will need an aggressive sales plan.
The recent disappointing sales of drug-coated devices for peripheral arterial disease look likely to become the norm.